Cell Signaling Technology, Inc. (CST) of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. (Astellas) of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics….
Scientists suggest new vitamin D-fortified bread to solve insufficiency problem
With most people unable to get enough vitamin D from sunlight or foods, scientists are suggesting that a new vitamin D-fortified food – bread made with high-vitamin D yeast – could fill…
Scientists complete protein 3D structural sequence essential for cellular function
Researchers at IRB Barcelona have completed the 3D structural sequence adopted by several essential proteins in the exchange of substances between the extra and intracellular milieu. This finding provides a global perspective…
UCSF study shows increased contraceptive supply decreases unintended pregnancy rates
Rates of unintended pregnancies and abortions decrease significantly when women receive a one-year supply of oral contraceptives, instead of being prescribed one- or three-month supplies, a UCSF study shows. Researchers observed a…
FDA approves ONGLYZA to treat type 2 diabetes patients with renal impairment
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration has approved the inclusion of data from two clinical studies in an update to…
Aminothiazoles as therapeutic leads for prion diseases
Scientists who examined more than 10,000 chemical compounds during the last year in search of potential new drugs for a group of untreatable brain diseases, are reporting that one substance shows unusual…
Bacteria and fungi may protect against asthma in rural children: Study
Children who grow up on farms are less likely to suffer from asthma than other rural children. An international team of researchers including Dr. Markus Ege and Professor Erika von Mutius at…
Nonsurgical methods to identify critical lymph nodes in patients with breast cancer
Researchers at the University of California, San Diego are developing nonsurgical methods for identifying critical lymph nodes to help doctors determine courses of treatment for breast cancer patients. The “sentinel lymph node”…
ACT receives patent for its single-blastomere technology
Advanced Cell Technology, Inc. (“ACT”; OTC Bulletin Board: ACTC), a leader in the field of regenerative medicine, announced today that it has been issued a patent on its “single-blastomere” technique. Patent Number…
California researchers receive InHealth grant to evaluate device-intensive procedures
The Institute for Health Technology Studies (InHealth) has awarded a $263,000 grant to a research team at the University of California, Berkeley, to identify and analyze the strategies that hospital systems employ…
Novo Nordisk submits rFXIII BLA to FDA for tratment of inherited bleeding disorder
Novo Nordisk announced today that a Biologic License Application (BLA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting the approval of a recombinant factor XIII compound (rFXIII) for…
PCI Biotech completes patient inclusion in PC-A11 phase I/II study to treat cancer
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that it has completed the inclusion of patients in its phase I/II study of its lead candidate PC-A11 in cancer patients. The last…
New study suggests variation in PCLO gene can contribute to risk of bipolar disorder
Understanding the genetics of bipolar disorder could lead to new treatments, but identifying specific genetic variations associated with this disorder has been challenging. A new study in Biological Psychiatry implicates a brain…
New research: Alzheimer’s disease may be easily misdiagnosed in elder people
New research shows that Alzheimer’s disease and other dementing illnesses may be easily misdiagnosed in the elderly, according to early results of a study of people in Hawaii who had their brains…
Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure
Trevena Inc., the leader in G-protein coupled receptor (GPCR) biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin…